Blanchard Cheryl R
SEC-identified person · CIK 1326530 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Xilio Therapeutics, Inc. XLO | Director | filed 2026–2026 |
| Anika Therapeutics, Inc. ANIK | Director · President, CEO, Director | filed 2018–2026 |
| Vigil Neuroscience, Inc. VIGL | Director | filed 2022–2025 |
| Dare Bioscience, Inc. DARE | Director | filed 2019–2023 |
| Neuronetics, Inc. STIM | Director | filed 2019–2020 |
| Seaspine Holdings Corp SPNE | Director | filed 2015–2018 |
| Zimmer Holdings INC ZMH | Sr. VP, Chief Scientific Off. | filed 2006–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.